FierceBiotech celebrates Independence Day

The FierceBiotech team is taking some time off to relax and celebrate the holiday. The newsletter won't be published on Monday, July 4th, but we'll be back to our regular schedule next Tuesday. Enjoy the long weekend! - Maureen Martino (twitter | email)

P.S. BIO 2011 is a wrap, but you can click here to catch up on any BIO 2011 coverage you missed. We look forward to seeing you in Boston next year!

Suggested Articles

Combining inhibitors of KRAS-G12C, mTOR and IGF1R can significantly shrink lung tumors in mice and human cancer cells, a study found.

X4 Pharmaceuticals has a new R&D chief: Renato Skerlj, who founded the company alongside CEO Paula Ragan and biotech luminary Henri Termeer.

Henlius Biotech missed the $477 million goal it set for its IPO, but still made the top five biopharma IPOs this year with its $410 million listing.